Careers in Biotechnology/Drug Development

A recently read a review of a new book entitled “Career Opportunities in Biotechnology and Drug Development” by Toby Freedman, 2008, Cold Spring Harbor Press. Freedman is a PhD molecular biologist that has moved into life sciences recruiting. Since I’m alway interested in career development, and biotech is a field I don’t know enough about, I thought I’d check it out.

I must admit I was highly impressed with the material. The book discusses current conventional wisdom for scientists who are concerned about their careers. Freedman totes that “there are lots of jobs in the biopharma industry”, so it’s worth looking there for options. But what are those jobs? Freedman then proceeds to give a comprehensive answer to that question.

Along the way, she provides a detailed description of the drug discovery process.

The first 6 chapters of this book provide general career advice, giving an overview of what is expected in the biopharma industry, what it takes to succeed, how to write a resume, network, etc. Most of the advice applies to all jobs, but some is specific to science or these industries. The advice is very good, and includes lots of details, examples, and resources for further information. Freedman provides a balanced overview, pointing out both the good and bad points of this industry.

The industry she is focusing on includes both biotechnology and drug discovery & development, also called biopharma. These industries have a great deal in common, and similar career paths and positions are available in each. The entire process is very complex, and often not well understood by those who have not been immersed in it.

The second, and major, part of the book breaks the drug discovery enterprise down into its various stages, describes the role of each step in the process, and details positions available at each stage.

The positions described range from those that require a PhD or MD, to those that are accessible to those with a college degree.

Freedman describes the types of positions, typical job titles and career paths, roles and responsibilities, typical tasks, relative salaries and other compensation. She also describes in detail the pros and cons of each field, how to excel in the field, and what personal characteristics are most often found in those who succeed in that field.

She predicts where the field is going and what job prospects will be like, and also talks about how to get started in each field.

Finally, each chapter ends with recommendations for training, professional societies, and other resources. The entire volume is well organized, with important points in callouts, and many clarifying diagrams.

Anyone who reads this book will come away (like I did) with a deeper understanding of the drug discovery industry, and how complex it really is (and perhaps why marketed pharmaceuticals really cost more than you’d think).

Hopefully, they will also come away with several ideas of places they might fit into that industry, and the resources and inspiration to start investigating those options. I would have liked to have seen more statistics and numbers (salaries, etc), but understand that data would get dated quickly, and ACS members can get current information from the Salary Comparator.

As further proof of the growing importance of this field, ACS has started an Industry Forum and their first speaker is from Wyeth Drug Discovery and Development. The free teleconference is coming up on Thursday, September 11th. While I may never work in a traditional job in this field, it is certainly an area I am going to keep an eye on, and learn more about.

This article was written by freelance technical writer Lisa M. Balbes, Ph.D. of Balbes Consultants.

-Lisa M. Balbes, Ph.D. Scientific Communication Services since 1992, Balbes Consultants http://www.balbes.com/   http://www.linkedin.com/in/lisabalbes –

 Author of:  “Nontraditional Careers for Chemists,” published by Oxford University Press (2006)

 

 

ACS Careers Industry Forum:  Monthly Teleconferences featuring Luminaries in the Chemical Sciences.

We feel this is a great opportunity for practitioners in the chemical sciences to listen in to top industry leaders in their industries and will assist in making informed career decisions. Guest Speakers include

ØSeptember:  Dr. Abou-Gharbia, Senior Vice President & Head of Chemical & Screening Sciences, for Wyeth Drug Discovery & Development.

ØOctober:  Dr. Carolyn Ribes, Process Analytical, Dow Benelux, B.V., Terneuzen, The Netherlands.

ØNovember:  Michael Strem, Ph.D., President, Strem Chemicals, Inc. founded Strem Chemicals in Newburyport, MA.

ØDecember:  No teleconference to be scheduled.

ØJanuary:  Dr. Tom Lane, to be President of ACS.

ØFebruary:  Dr. William F. Carroll, Jr., Vice President, Chlorovinyl Issues for OxyChem and works on public policy issues and communications related to chlorine and PVC.  He is also Adjunct Professor of Chemistry at Indiana University, Bloomington, Indiana where he teaches polymer chemistry.

Please join us to discuss economic and employment trends with top industry executives in the chemical sciences.  Go to register now.  This is a free service via conference call.

 

 

 

 

 

 

Climate Change and Jobs

If you’re at all thinking of a career in the chemical industry, or if you already have a job as an industrial chemist (or if you’re a policy wonk like me), then I recommend you download a free copy of a new report from the Peterson Institute for International Economics and the World Resources Institute (http://pdf.wri.org/leveling_the_carbon_playing_field.pdf). Titled, “Leveling The Carbon Playing Field: International Competition and U.S. Climate Policy Design,” the report examines the possibles effect of various proposed legislation on energy intensive industries such as the chemical, refining, and paper industries, all major employers of chemists and chemical engineers.

One of the first things that struck me about this report is that the five most carbon-intensive industries other than petroleum refining, which includes cement, steel, aluminum, paper, and chemicals, account for only 5.6 percent of direct U.S. carbon dioxide emissions. Yet these five industries would be hit disproportionately by either a carbon tax of $10/ton (the most common figure bandied about) or a mandatory cap-and-trade system. More importantly as far as employment goes, each of these industries would be put at a competitive disadvantage on the world market unless and until a global carbon reduction mechanism was put in place.

Fortunately, policymakers are aware of the potential impact of U.S. climate policy on these industries. The various pieces of legislation making their way through subcommittee hearings all include options for addressing the competitive impact of either a carbon tax or carbon trading scheme. These options include:

· Reducing the cost of compliance for U.S. industries that will be hardest hit;

· Imposing border taxes or other adjustments that would impose equalizing costs on competitive importers; and

· Encouraging other countries to impose similar costs on their industries

Unfortunately, what works for one industry may not work for others, say the authors of this report. And neither of the first two options is likely to work over the long haul unless the nations of the world can agree upon and enact an international framework for controlling emissions.

Back in March, leaders of the U.S. chemical industry testified before Congress that energy and raw material costs will skyrocket if mandatory limits are placed on greenhouse gas emissions. But that doesn’t mean that the industry is stonewalling efforts to craft such limits. Indeed, companies such as Dow Chemical, DuPont, BP America, and ConocoPhillips are members of the U.S. Climate Action Partnership, a coalition that has accepted the fact that regulation will occur.

What concerns the chemical industry the most is that legislation not prompt a wholesale switch to natural gas by the nation’s electric utility companies, which the industry believes – as do most economists – would send natural gas prices soaring even higher than they are today. And given that natural gas is a major feedstock for the chemical industry, any dramatic increase in natural gas prices would pummel the U.S. chemical industry.

While there are too many instances of industries crying wolf when it comes to climate regulations, I have to agree with the chemical industry on this one. Why? Natural gas prices have tripled since the late 1990s and according to estimates from the American Chemistry Council, more than 100,000 industry workers have lost jobs as their employers relocated to countries with cheaper natural gas.

The playing field has to be level. The future of jobs in the U.S. chemical industry depends on it.

This article was written by Joe Alper, a freelance science writer and technology analyst in Louisville, CO, who writes frequently for the ACS journal Analytical Chemistry.

********************************************************************************************

BE A PART: ACS Careers Job Fair

Are you interested in speaking with employers to discuss employment opportunities? Perhaps you would like to brush up on your interviewing skills, find out how to write a winning resume, or get valuable information on various career management and development topics. The ACS Career Fair can provide all of these things and more!

The ACS Career Fair at the 236th National Meeting in Philadelphia will offer employment services in Hall D of the Convention Center, Sunday, August 17 through Tuesday, August 19 from 8 AM to 5:30 PM, and on Wednesday, August 20 from 8 AM to 12 PM. Job seekers and employers will be provided a venue to meet and discuss job opportunities.

The ACS Career Fair is open to ACS members and national and student affiliates. All job seekers must sign up online to participate from June 23-August 20, 2008 at http://www.acs.org/careers/jobseekers.

If you are not an ACS Member we strongly encourage you to join.